These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10390166)

  • 21. Understanding Alzheimer's disease: expect more genes and other things.
    Mayeux R
    Ann Neurol; 1996 Jun; 39(6):689-90. PubMed ID: 8651638
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene-gene interaction between interleukin-6 and alpha2-macroglobulin influences the risk for Alzheimer's disease.
    Bagli M; Papassotiropoulos A; Jessen F; Rao ML; Maier W; Heun R
    Ann Neurol; 2000 Jan; 47(1):138-9. PubMed ID: 10632118
    [No Abstract]   [Full Text] [Related]  

  • 23. No association between apolipoprotein A-IV codon 360 mutation and late-onset Alzheimer's disease in the Japanese population.
    Ji Y; Urakami K; Adachi Y; Nakashima K
    Dement Geriatr Cogn Disord; 1999; 10(6):473-5. PubMed ID: 10559562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
    Kehoe P; Williams J; Lovestone S; Wilcock G; Owen MJ
    Lancet; 1996 Apr; 347(9009):1185. PubMed ID: 8609781
    [No Abstract]   [Full Text] [Related]  

  • 25. [A study on mutation of exon 5 of presenilin-1 in Alzheimer's disease].
    Ma Q; Qian C; Liu Z; Lu X; Lin H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec; 16(6):349-52. PubMed ID: 10581340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against Alzheimer's disease with apoE epsilon 2.
    Talbot C; Lendon C; Craddock N; Shears S; Morris JC; Goate A
    Lancet; 1994 Jun; 343(8910):1432-3. PubMed ID: 7910910
    [No Abstract]   [Full Text] [Related]  

  • 28. Aluminum and Alzheimer's disease.
    Munoz DG
    CMAJ; 1995 Feb; 152(4):468-9. PubMed ID: 7859191
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of methylenetetrahydrofolate reductase polymorphisms with susceptibility to Alzheimer's disease.
    Mansouri L; Fekih-Mrissa N; Klai S; Mansour M; Gritli N; Mrissa R
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1693-6. PubMed ID: 23659764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Alzheimer's disease. Clinical practice].
    Defontaines B
    Rev Prat; 1998 Nov; 48(17):1923-7. PubMed ID: 9854396
    [No Abstract]   [Full Text] [Related]  

  • 31. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
    Lucotte G; David F; Visvikis S; Leininger-Müller B; Siest G; Babron MC; Couderc R
    Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901625
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical correlates of apolipoprotein E in Alzheimer's disease.
    Frisoni GB; Bianchetti A; Govoni S; Trabucchi M
    Ann Neurol; 1996 Oct; 40(4):688-9. PubMed ID: 8871593
    [No Abstract]   [Full Text] [Related]  

  • 33. Apolipoprotein E and Alzheimer's disease.
    Scott J
    Lancet; 1993 Sep; 342(8873):696. PubMed ID: 8103818
    [No Abstract]   [Full Text] [Related]  

  • 34. Alzheimer's disease.
    Owen M; Liddell M; McGuffin P
    BMJ; 1994 Mar; 308(6930):672-3. PubMed ID: 8142788
    [No Abstract]   [Full Text] [Related]  

  • 35. No effect of the alpha1-antichymotrypsin A allele in Alzheimer's disease.
    Didierjean O; Martinez M; Campion D; Hannequin D; Dubois B; Martin C; Puel M; Thomas Anterion C; Pasquier F; Moreau O; Babron MC; Penet C; Agid Y; Clerget-Darpoux F; Frebourg T; Brice A
    J Neurol Neurosurg Psychiatry; 1997 Jul; 63(1):103-5. PubMed ID: 9221977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.
    Chartier-Harlin MC; Crawford F; Houlden H; Warren A; Hughes D; Fidani L; Goate A; Rossor M; Roques P; Hardy J
    Nature; 1991 Oct; 353(6347):844-6. PubMed ID: 1944558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease and the apolipoprotein E epsilon 4 allele.
    Friedman G; Ben Yehuda A
    Isr J Med Sci; 1994 Jul; 30(7):545-7. PubMed ID: 8050887
    [No Abstract]   [Full Text] [Related]  

  • 38. Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Cuyvers E; De Roeck A; Van den Bossche T; Van Cauwenberghe C; Bettens K; Vermeulen S; Mattheijssens M; Peeters K; Engelborghs S; Vandenbulcke M; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Sleegers K
    Lancet Neurol; 2015 Aug; 14(8):814-822. PubMed ID: 26141617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease and the beta amyloid gene.
    Harrison PJ
    BMJ; 1991 Jun; 302(6791):1478-9. PubMed ID: 1906764
    [No Abstract]   [Full Text] [Related]  

  • 40. The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: an additional fifteen families.
    Murrell J; Ghetti B; Cochran E; Macias-Islas MA; Medina L; Varpetian A; Cummings JL; Mendez MF; Kawas C; Chui H; Ringman JM
    Neurogenetics; 2006 Nov; 7(4):277-9. PubMed ID: 16897084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.